Larue D Carter Memorial Hospital

Indianapolis, Indiana 46222

0 studies enrolling now · 3 studies all time

What they study most

Borderline Personality Disorder, Schizophrenia

Studies at this site

• The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia — Stopped early
• Fingolimod in Schizophrenia Patients — Completed
• Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) — Stopped early